Browse the complete record of transactions filed by 서상준, Conseiller. Insider active across 2 companies, notably 에이프릴바이오. Aggregated, 17,943 filings have been published. History available since 4 March 2026. The latest transaction was disclosed on 4 March 2026 (Purchase). Regulator: DART (FSS). All data is openly available.
Seo Sang-jun is an Advisor at 에이프릴바이오, a biotechnology company. In this role, he provides strategic advice and participates in decision-making within the company. His expertise is valuable for developing new solutions.